These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31520536)
1. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom. Chen SC; Dastamani A; Pintus D; Yau D; Aftab S; Bath L; Swinburne C; Hunter L; Giardini A; Christov G; Senniappan S; Banerjee I; Shaikh MG; Shah P Clin Endocrinol (Oxf); 2019 Dec; 91(6):770-775. PubMed ID: 31520536 [TBL] [Abstract][Full Text] [Related]
2. Paradoxical hypoglycaemia associated with diazoxide therapy for hyperinsulinaemic hypoglycaemia. Ponmani C; Gannon H; Hussain K; Senniappan S Horm Res Paediatr; 2013; 80(2):129-33. PubMed ID: 23886961 [TBL] [Abstract][Full Text] [Related]
3. Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review. Timlin MR; Black AB; Delaney HM; Matos RI; Percival CS Pediatr Cardiol; 2017 Aug; 38(6):1247-1250. PubMed ID: 28642988 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant. Ohnishi Y; Okada S; Yasudo H; Kimura S; Suzuki Y; Hasegawa S Int Heart J; 2020 Sep; 61(5):1084-1087. PubMed ID: 32921661 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide. Herrera A; Vajravelu ME; Givler S; Mitteer L; Avitabile CM; Lord K; De León DD J Clin Endocrinol Metab; 2018 Dec; 103(12):4365-4372. PubMed ID: 30247666 [TBL] [Abstract][Full Text] [Related]
8. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia. Banerjee I; Salomon-Estebanez M; Shah P; Nicholson J; Cosgrove KE; Dunne MJ Diabet Med; 2019 Jan; 36(1):9-21. PubMed ID: 30246418 [TBL] [Abstract][Full Text] [Related]
9. Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia. Senniappan S; Sadeghizadeh A; Flanagan SE; Ellard S; Hashemipour M; Hosseinzadeh M; Salehi M; Hussain K BMC Res Notes; 2015 Aug; 8():350. PubMed ID: 26268944 [TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation. Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534 [TBL] [Abstract][Full Text] [Related]
11. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening. Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515 [TBL] [Abstract][Full Text] [Related]
12. When is it best to discontinue diazoxide in children with persistent hyperinsulinaemic hypoglycaemia and negative genetics for K Güemes M; Kostopoulou E; AlYahyaei M; Gilbert C; Shah P Clin Endocrinol (Oxf); 2022 Feb; 96(2):107-113. PubMed ID: 34370339 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia. Chandran S; R PR; Mei Chien C; Saffari SE; Rajadurai VS; Yap F Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):359-363. PubMed ID: 34544689 [TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects. Balachandran B; Mukhopadhyay K; Sachdeva N; Walia R; Attri SV Acta Paediatr; 2018 Jun; 107(6):990-995. PubMed ID: 29385640 [TBL] [Abstract][Full Text] [Related]
16. Case report: A novel Chandran S; Verma D; Rajadurai VS; Yap F Front Endocrinol (Lausanne); 2024; 15():1471596. PubMed ID: 39421536 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy. Yildizdas D; Erdem S; Küçükosmanoglu O; Yilmaz M; Yüksel B Adv Ther; 2008 May; 25(5):515-9. PubMed ID: 18512033 [TBL] [Abstract][Full Text] [Related]
18. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation. Shah P; Arya VB; Flanagan SE; Morgan K; Ellard S; Senniappan S; Hussain K J Pediatr Endocrinol Metab; 2015 May; 28(5-6):695-9. PubMed ID: 25518065 [TBL] [Abstract][Full Text] [Related]